Healthcare provider profile · identity verified

Rebecca Wolfe, MD

Family Practice · WYOMING, MI · NPI 1881799492

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	429	45
Trazodone Hcl	Trazodone Hcl	321	32
Gabapentin	Gabapentin	257	30
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	237	25
Amlodipine Besylate	Amlodipine Besylate	233	24
Eliquis	Apixaban	205	21
Lisinopril	Lisinopril	194	20
Levothyroxine Sodium	Levothyroxine Sodium	188	19
Metoprolol Succinate	Metoprolol Succinate	178	22
Omeprazole	Omeprazole	175	24
Sertraline Hcl	Sertraline Hcl	169	21
Duloxetine Hcl	Duloxetine Hcl	135	12
Losartan Potassium	Losartan Potassium	131	15
Carvedilol	Carvedilol	129	11
Escitalopram Oxalate	Escitalopram Oxalate	126	16
Fluoxetine Hcl	Fluoxetine Hcl	120	13
Dapagliflozin	Dapagliflozin Propanediol	114	14
Bupropion Xl	Bupropion Hcl	109	11
Tamsulosin Hcl	Tamsulosin Hcl	109	17
Metformin Hcl	Metformin Hcl	103	12
Risperidone	Risperidone	103	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	102	13
Tramadol Hcl	Tramadol Hcl	102	21
Potassium Chloride	Potassium Chloride	100	13
Spironolactone	Spironolactone	99	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	97	13
Esomeprazole Magnesium	Esomeprazole Magnesium	90	suppressed
Furosemide	Furosemide	84	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	20
Hydralazine Hcl	Hydralazine Hcl	80	suppressed
Famotidine	Famotidine	79	13
Alendronate Sodium	Alendronate Sodium	77	suppressed
Buspirone Hcl	Buspirone Hcl	76	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	75	suppressed
Lorazepam	Lorazepam	65	20
Glipizide Er	Glipizide	63	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	61	suppressed
Bumetanide	Bumetanide	60	suppressed
Trospium Chloride	Trospium Chloride	59	suppressed
Mirtazapine	Mirtazapine	54	12
Lamotrigine	Lamotrigine	53	suppressed
Pregabalin	Pregabalin	53	suppressed
Divalproex Sodium Er	Divalproex Sodium	52	suppressed
Clonazepam	Clonazepam	51	suppressed
Naproxen	Naproxen	49	suppressed
Nystatin	Nystatin	49	15
Ranolazine Er	Ranolazine	47	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Metformin Hcl Er	Metformin Hcl	42	suppressed
Prazosin Hcl	Prazosin Hcl	42	suppressed
Olanzapine	Olanzapine	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	14
Baclofen	Baclofen	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Torsemide	Torsemide	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Carvedilol Er	Carvedilol Phosphate	32	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	31	suppressed
Trulicity	Dulaglutide	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Benztropine Mesylate	Benztropine Mesylate	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Mirabegron Er	Mirabegron	26	suppressed
Buprenorphine	Buprenorphine	25	suppressed
Prednisone	Prednisone	25	14
Celecoxib	Celecoxib	24	suppressed
Cosentyx Sensoready (2 Pens)	Secukinumab	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Primidone	Primidone	23	suppressed
Digoxin	Digoxin	22	suppressed
Haloperidol	Haloperidol	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Naltrexone Hcl	Naltrexone Hcl	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	20	suppressed
Ozempic	Semaglutide	20	suppressed
Steglatro	Ertugliflozin Pidolate	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Oxcarbazepine	Oxcarbazepine	18	suppressed
Zonisamide	Zonisamide	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Topiramate	Topiramate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	11
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Aristada	Aripiprazole Lauroxil	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	13	suppressed
Velphoro	Sucroferric Oxyhydroxide	13	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	12	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Nadolol	Nadolol	12	suppressed
Nateglinide	Nateglinide	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Enbrel Sureclick	Etanercept	11	suppressed
Invega Sustenna	Paliperidone Palmitate	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Mounjaro	Tirzepatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error